Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Roche Holding AG Basel American Depositary Shares (OP:RHHBY)

56.75 -0.27 (-0.47%)
Streaming Delayed Price Updated: 3:59 PM EST, Jan 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Roche Holding AG Basel American Depositary Shares

< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
35 36 Next >
News headline image
Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
Amgen's Lumakras/Keytruda/Tecentriq Combo Data Flags Safety Concern ↗
 
Via Benzinga
News headline image
These 2 Under-The-Radar Stocks Traded More Than $1B Each Last Month ↗
The month of July saw $37.3 billion in trading volume for stocks that trade on the OTCQK and OTCQB. While some of the stocks that trade over-the-counter are considered penny stocks based on their share... 
Via Benzinga
News headline image
Kiniksa Inks Global License Agreement With Roche For Vixarelimab ↗
 
Via Benzinga
News headline image
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
Poseida Shares Rally As Roche Takes Next Big Step Into Allogeneic CAR-T Field ↗
 
Via Benzinga
News headline image
Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
Genentech’s Subcutaneous Formulation of Tecentriq Demonstrates Positive Phase III Results
From Genentech
Via Business Wire
News headline image
Blue Chip Stocks In Focus: Roche Holding AG ↗
When examining blue chip stocks, rarely do international companies get brought up. However, there are multiple overseas companies with an established track record of value creation and robust... 
Via Talk Markets
News headline image
Daily Biotech Pulse: Bausch Health To Appeal Xifaxan Patent Decision, Bristol Myers Drug Combo Fails In Kidney Cancer Trial, Sarepta's Duchenne Candidate Update ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
Genentech to Present Scientific Progress Across Alzheimer’s Disease Pharmaceutical and Diagnostic Portfolio at 2022 AAIC Annual Meeting
From Genentech
Via Business Wire
News headline image
Regeneron's Price Target Cut On Dim Prospects For Its Flagship Eye Product ↗
 
Via Benzinga
News headline image
Daily Biotech Pulse: Liver Disease-Focused Gene Therapy Pact, Assembly Bio Stops HBV Infection Trial, X4 Pharma Looks For Partners ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
Benzinga Before The Bell: Baidu Beats Tesla, Finland Sells $47.5M Bitcoins, Tesla's Bitcoin Sale And Other Top Financial Stories Thursday, July 21 ↗
CNBC 
Via Benzinga
News headline image
Roche's Long-Time CEO Passes Baton, Higher Diagnostics, Medicine Sales Lift 1H Sales & Profit ↗
 
Via Benzinga
News headline image
Novartis Posts Mixed Q2 Earnings, Expects Improved Earnings At Sandoz ↗
 
Via Benzinga
News headline image
Mortgage Financiers & Crypto Securities Reclaim Their Spots As Most Actively Traded Securities On OTC Markets In June ↗
Reflecting the expected conditions of a bear market, many of the world’s indices saw a decrease in price throughout June. 
Via Benzinga
News headline image
Roche Launches Dual Antigen & Antibody Hepatitis C Diagnostic Test ↗
 
Via Benzinga
News headline image
New Two-Year Data Confirm Genentech’s Vabysmo Improves Vision With Fewer Treatments for People With Wet Age-Related Macular Degeneration
From Genentech
Via Business Wire
News headline image
Why 'Covid Fatigue' Isn't Enough To Keep BioNTech Down; Shares Surge On Upgrade ↗
BioNTech won an upgrade Wednesday. Here's what one analyst expects to drive growth. 
Via Investor's Business Daily
News headline image
New Data Reinforce Favorable Safety, Efficacy Of Roche's Hemlibra For Hemophilia A ↗
 
Via Benzinga
News headline image
The Daily Biotech Pulse: Europe Approves Second Round Of Booster Doses of mRNA COVID-19 Vaccines, Perrigo Seeks Approval For First OTC Birth Control Pill, MacroGenics Closes Head & Cancer Study After Patient Death ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
New Data From Phase III HAVEN 6 Study Reinforce Favorable Safety and Efficacy Profile of Genentech’s Hemlibra (emicizumab-kxwh) in People With Moderate or Mild Hemophilia A
From Genentech
Via Business Wire
News headline image
Merck Reportedly Eyes $40 Billion Seagen Tie-Up; Will The Deal Save Biotech? ↗
Two major cancer players are reportedly closing in on a massive merger. 
Via Investor's Business Daily
News headline image
Is Merck Stock A Buy Amid Reports It Could Buy Seagen For $40 Billion? ↗
Is Merck stock a buy as reports suggest it could put up $40 billion to acquire Seagen? Is MRK stock a buy right now? 
Via Investor's Business Daily
News headline image
10 Most Traded OTC Stocks In June: Where Do Danone, Adidas And Grayscale Bitcoin Trust Rank? ↗
The month of June saw $45.2 billion in trading volume for stocks that trade on the OTCQK and OTCQB. While some of the stocks that trade over-the-counter are considered penny stocks based on their share... 
Via Benzinga
News headline image
Sarepta Reports One Heart Inflammation Case In Duchenne Gene Therapy Trial ↗
 
Via Benzinga
News headline image
The Daily Biotech Pulse: FDA Decision On Biogen Alzheimer's Drug Due In January, FDA Reviews Roche's Lymphoma Candidate, Rare Pediatric Tag For Kazia's Pediatric Brain Cancer Candidate ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
FDA Grants Priority Review to Genentech’s Mosunetuzumab for People With Relapsed or Refractory Follicular Lymphoma
From Genentech
Via Business Wire
News headline image
Celldex Therapeutics Skids As It Takes On A Blockbuster Roche, Novartis Drug ↗
The study was in 26 patients with chronic hives that don't respond to antihistamines. 
Via Investor's Business Daily
< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
35 36 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.